Nous aimerions que vous fassiez partie de notre communauté. Rejoignez notre Discord pour échanger avec nous et les autres membres !

Ticker
NSIS-B.CO

Price
408.00
Stock movement down
-1.30 (-0.31%)
Company name
Novonesis (Novozymes) A/S
Exchange
(CO
,
Currency
DKK
)
Sector
Basic Materials >
Specialty Chemicals
Capitalisation boursière
172.65B
Valeur d'entreprise
-
Cours/chiffre d'affaires
-
Cours/valeur comptable
-
Rendement du div
1.91%
Croissance du div
-
Années de croissance
-
Versement FCF
-
Trailing P/E
-
P/E prévisionnel
26.27
PEG
-
Croissance EPS
-
Rendement sur 1 an
-3.61%
Rendement sur 3 ans
-3.24%
Rendement sur 5 ans
1.81%
Rendement sur 10 ans
1.96%
Dernière modification : 2025-09-17

DIVIDENDES

NSIS-B.CO ne verse pas de dividendes

VALORISATION

Ratios de valorisation

Loading...
Données de ratios de valorisation
Trailing P/E-
Cours/OCF-
Cours/FCF-
Cours/EBITDA-
EV/EBITDA-

Valorisation (Chiffre d'affaires/valeur comptable)

Loading...
Données de valorisation (Chiffre d'affaires/valeur comptable)
Cours/chiffre d'affaires-
Cours/valeur comptable-
EV/chiffre d'affaires-

DONNEES FINANCIERES

INFORMATIONS SUR LES ACTIONS

Graphique boursier

Loading...
Données du prix des actions
Ouverture419.80
Max journalier424.30
Min journalier417.60
Volume journalier593K
Niveau record537.20
Estimation des analystes sur 1 an469.45
Beta0.55
EPS (TTM)-
Dividende par action8.00
Date ex-div21 Aug 2025
Prochaine date de bénéfices-

Potentiel de baisse

Loading...
Données du potentiel de baisse
NSIS-B.COS&P500
Baisse de prix actuelle par rapport au niveau record-24.05%-0.20%
Baisse de prix actuelle la plus importante-52.86%-19.00%
Date de la baisse la plus importante27 Oct 20088 Apr 2025
Baisse moyenne par rapport au record-14.21%-2.76%
Délai moyen pour nouveau record23 days5 days
Délai max pour nouveau record1127 days89 days
INFORMATIONS SUR LA SOCIETE
NSIS-B.CO (Novonesis (Novozymes) A/S) company logo
Capitalisation boursière
172.65B
Catégorie de capitalisation boursière
Large-cap
Description
Novozymes A/S produces and sells industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, the Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company provides biosolutions for the food and beverage industry, such as dairy, baking, beverage, meat, plant-based, functional, and other foods, as well as protein solutions and early lie nutrition. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services. In addition, the company provides dishwashing, softener, and microbial and medical cleaning services. Further, it offers corn, cotton, forages, peanuts, pulses, soybeans, wheat, small grains, bioyield, and biocontrol solutions; warm water species, recirculating aquaculture system; animal health and nutrition solutions; and fiber modification, bleach boosting, deposit control, and starch modification solutions. Additionally, the company provides carbon capture, leather and textiles solutions; enzyme solutions, including corn and wheat separation, liquefaction, saccharification, filtration, isomerization, maltose, and specialties solutions; warm water species and recirculating aquaculture system solutions; human health solutions comprising brain, oral, protective and immune, and gastrointestinal health solutions; ethanol, biodiesel, renewable diesel, wastewater, sewage, and renewable diesel solutions; and agriculture and industry, biogas food waste, food waste, biocatalysis, cell culture, enzyme, and biogas solutions. It also provides lipases, proteases, oxidoreductases, and carbohydrases. Novozymes A/S was founded in 1925 and is based in Lyngby, Denmark.
Employés
10582
Communication financière
-
CEO
Pays
Denmark
Ville
Type d'action
-
Statut CCC
-
Fréquences des dividendes
-
EVENEMENTS ET PRESENTATIONS
EvénementsPrésentations
Loading...
COMPRENDRE LE METIER
Loading...
ACTUALITES DE LA SOCIETE
Toute l'actualitéCommuniqués de presse
KMDA vs. NVZMY: Which Stock Is the Better Value Option?
31 octobre 2025
Noma and Novonesis partner to scale deliciousnessNoma, hailed as one of the world’s best restaurants, is joining forces with Novonesis, the global leader in biosolutions, to take deliciousness to the ...
23 octobre 2025
Novo Holdings plans to elect Lars Green, former CFO of Novozymes (now Novonesis), as Chair of its Board of Directors and Britt Meelby Jensen, CEO of Ambu, as Vice Chair. Lars Rebien Sørensen will step...
21 octobre 2025
Manufacturing Day at Novonesis Tue Micheelsen, President, Novonesis North America and Carolyn Lee, President & Executive Director of the Manufacturing Institute accompany students on a Novonesis tour ...
6 octobre 2025
Novozymes (CPSE:NSIS B) might not be grabbing headlines with earth-shaking news right now, but that doesn’t mean investors should overlook what’s happening under the surface. Even modest moves can sig...
9 septembre 2025
Novonesis and Novo Nordisk have announced a research partnership to explore how the gut microbiome influences metabolic health, aiming to develop synbiotic food supplements and identify novel health b...
8 septembre 2025
Novonesis and Novo Nordisk join forces in a new research collaboration to explore solutions that seek to preserve and optimize metabolic health and well-being for people. COPENHAGEN, Denmark – Septemb...
8 septembre 2025
Corbion’s Supervisory Board announces it has nominated Per Falholt for appointment to the Supervisory Board for a term of four years as of the Annual General Meeting of Shareholders (AGM) in May 2026....
26 août 2025
COPENHAGEN, Denmark – August 21, 2025. Novonesis delivered 9% organic sales growth in H1 and full-year outlook range narrowed to 6-8%. Ester Baiget, President & CEO: “I’m very pleased with 9% organic ...
21 août 2025
9% organic sales growth in H1 and FY outlook range narrowed to 6-8% Ester Baiget, President & CEO: “I’m very pleased with 9% organic sales growth in the first half of the year. Demand for our biosolut...
21 août 2025
Page suivante